Skip to main content

Vascular Anomalies of the Neonatal Airway

  • Chapter
  • First Online:
Disorders of the Neonatal Airway

Abstract

While vascular anomalies may be found in patients of all ages, they most commonly present in neonates and infants. Such lesions usually involve the skin and subcutaneous tissues; however the mucosa and viscera may also be affected. When present in the neonatal airway, vascular anomalies may cause severe respiratory distress, hypoxemia, failure to thrive, and even death.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 159.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Mulliken JB, Glowacki J. Hemangiomas and vascular malformations in infants and children: a classification based on endothelial characteristics. Plast Reconstr Surg. 1982;69:412–22.

    Article  CAS  PubMed  Google Scholar 

  2. Enjolras O, Mulliken JB. Vascular tumors and vascular malformations (new issues). Adv Dermatol. 1997;13:375–423.

    CAS  PubMed  Google Scholar 

  3. Mulliken JB, Fishman SJ, Burrows PE. Vascular anomalies. Curr Probl Surg. 2000;37:517–84.

    Article  CAS  PubMed  Google Scholar 

  4. Rahbar R, McGill TJ, Mulliken JB. Vascular tumors and malformations of the head and neck. In: Cummings CW, Flint PW, editors. Otolaryngology head and neck surgery. 4th ed. Philadelphia: Mosby; 2005. p. 4013–20.

    Google Scholar 

  5. Kilcline C, Frieden IJ. Infantile hemangiomas: how common are they? A systematic review of the medical literature. Pediatr Dermatol. 2008;25:168–73.

    Article  PubMed  Google Scholar 

  6. Pratt AG. Birthmarks in infants. Arch Dermatol. 1953;67:302–5.

    Article  CAS  Google Scholar 

  7. Jacobs AH, Walton RG. The incidence of birthmarks in the neonate. Pediatrics. 1976;58:218–22.

    CAS  PubMed  Google Scholar 

  8. Dickison P, Christou E, Wargon O. A prospective study of infantile hemangiomas with a focus on incidence and risk factors. Pediatr Dermatol. 2011;28:663–9.

    Article  PubMed  Google Scholar 

  9. Hoornweg MJ, Smeulders MJ, Ubbink DT, van der Horst CM. The prevalence and risk factors of infantile haemangiomas: a case-control study in the Dutch population. Paediatr Perinat Epidemiol. 2012;26:156–62.

    Article  PubMed  Google Scholar 

  10. Haggstrom AN, Drolet BA, Baselga E, Chamlin SL, Garzon MC, Horii KA, et al. Prospective study of infantile hemangiomas: demographic, prenatal, and perinatal characteristics. J Pediatr. 2007;150:291–4.

    Article  PubMed  Google Scholar 

  11. Chiller KG, Passaro D, Frieden IJ. Hemangiomas of infancy: clinical characteristics, morphologic subtypes, and their relationship to race, ethnicity, and sex. Arch Dermatol. 2002;138:1567–76.

    Article  PubMed  Google Scholar 

  12. Amir J, Metzker A, Krikler R, Reisner SH. Strawberry hemangioma in preterm infants. Pediatr Dermatol. 1986;3:331–2.

    Article  CAS  PubMed  Google Scholar 

  13. Drolet BA, Swanson EA, Frieden IJ. Infantile hemangiomas: an emerging health issue linked to an increased rate of low birth weight infants. J Pediatr. 2008;153:712–5. e1.

    Article  PubMed  Google Scholar 

  14. Holinger PH, Brown WT. Congenital webs, cysts, laryngoceles and other anomalies of the larynx. Ann Otol Rhinol Laryngol. 1967;76:744–52.

    Article  CAS  PubMed  Google Scholar 

  15. Perkins JA, Oliaei S, Garrison MM, Manning SC, Christakis DA. Airway procedures and hemangiomas: treatment patterns and outcome in U.S. pediatric hospitals. Int J Pediatr Otorhinolaryngol. 2009;73:1302–7.

    Article  PubMed  Google Scholar 

  16. Shikhani AH, Marsh BR, Jones MM, et al. Infantile subglottic hemangiomas: an update. Ann Otol Rhinol Laryngol. 1986;95:336–47.

    Article  CAS  PubMed  Google Scholar 

  17. Sherrington CA, Sim DK, Freezer NJ, Robertson CF. Subglottic haemangioma. Arch Dis Child. 1997;76:458–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  18. Feuerstein SS. Subglottic hemangioma in infants. Laryngoscope. 1973;83:466–75.

    Article  CAS  PubMed  Google Scholar 

  19. Chatrath P, Black M, Jani P, et al. A review of the current management of infantile subglottic haemangioma, including a comparison of CO2 laser therapy versus tracheostomy. Int J Pediatr Otorhinolaryngol. 2002;64:143–57.

    Article  PubMed  Google Scholar 

  20. Hughes CA, Rezaee A, Ludemann JP, Holinger LD. Management of congenital subglottic hemangioma. J Otolaryngol. 1999;28:223–8.

    CAS  PubMed  Google Scholar 

  21. Yu Y, Flint AF, Mulliken JB, Wu JK, Bischoff J. Endothelial progenitor cells in infantile hemangioma. Blood. 2004;103:1373–5.

    Article  CAS  PubMed  Google Scholar 

  22. Greenberger S, Boscolo E, Adini I, Mulliken JB, Bischoff J. Corticosteroid suppression of VEGF-A in infantile hemangioma-derived stem cells. N Engl J Med. 2010;362:1005–13.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  23. North PC, Waner M, James CA, Mizeracki A, Frieden IJ, Mihm MC. Congenital nonprogressive hemangioma. A distinct clinicopathologic entity unlike infantile hemangioma. Arch Dermatol. 2001;137:1607–20.

    Article  CAS  PubMed  Google Scholar 

  24. North PE, Waner M, Mizeracki A, Mihm Jr MC. GLUT1: a newly discovered immunohistochemical marker for juvenile hemangiomas. Hum Pathol. 2000;31:11–22.

    Article  CAS  PubMed  Google Scholar 

  25. Leon-Villapalos J, Wolfe K, Kangesu L. GLUT1: an extra diagnostic tool to differentiate between haemangiomas and vascular malformations. Br J Plast Surg. 2005;58:348–52.

    Article  CAS  PubMed  Google Scholar 

  26. Greenberger S, Adini I, Biscolo E, Mulliken JB, Bischoff J. Targeting NF-kB in infantile hemangioma-derived stem cells reduces VEGF-A expression. Angiogenesis. 2010;13:327–35.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  27. Chang J, Most D, Bresnick S, Mehrara B, Steinbrech DS, Reinisch J, et al. Proliferative hemangiomas: analysis of cytokine gene expression and angiogenesis. Plast Reconstr Surg. 1999;103:1–9. discussion 10.

    Article  CAS  PubMed  Google Scholar 

  28. Razon MJ, Kräling BM, Mulliken JB, Bischoff J. Increased apoptosis coincides with onset of involution in infantile hemangioma. Microcirculation. 1998;5:189–95.

    Article  CAS  PubMed  Google Scholar 

  29. Colonna V, Resta L, Napoli A, Bonifazi E, et al. Placental hypoxia and neonatal haemangioma: clinical and histological observations. Br J Dermatol. 2010;162:208–9.

    Article  CAS  PubMed  Google Scholar 

  30. Drolet BA, Frieden IJ. Characteristics of infantile hemangiomas as clues to pathogenesis: does hypoxia connect the dots? Arch Dermatol. 2010;146:1295–9.

    Article  PubMed  Google Scholar 

  31. Kleinman ME, Blei F, Gurtner GC. Circulating endothelial progenitor cells and vascular anomalies. Lymphat Res Biol. 2005;3:234–9.

    Article  CAS  PubMed  Google Scholar 

  32. Bauland CG, Smit JM, Bartelink LR, Zondervan HA, Spauwen PH. Hemangioma in the newborn: increased incidence after chorionic villus sampling. Prenat Diagn. 2010;30:913–7.

    Article  PubMed  Google Scholar 

  33. Bauland CG, Smit JM, Scheffers SM, Bartels RH, van den Berg P, Zeebregts CJ, et al. Similar risk for hemangiomas after amniocentesis and transabdominal chorionic villus sampling. J Obstet Gynaecol Res. 2012;38:371–5.

    Article  PubMed  Google Scholar 

  34. Lister WA. Natural history of strawberry nevi. Lancet. 1938;231(5991):1429–30.

    Article  Google Scholar 

  35. Bivings L. Spontaneous regression of angiomas in children: twenty-two years’ observation covering 236 cases. J Pediatr. 1954;45:643–7.

    Article  CAS  PubMed  Google Scholar 

  36. Margileth AM, Museles M. Current concepts in diagnosis and management of congenital cutaneous hemangiomas. Pediatrics. 1965;36:410–6.

    CAS  PubMed  Google Scholar 

  37. Moroz B. Long-term follow-up of hemangiomas in children. In: Williams HB, editor. Symposium on vascular malformations and melanotic lesions. St Louis: CV Mosby; 1982. p. 27–35.

    Google Scholar 

  38. Mulliken JB. Diagnosis and natural history of hemangiomas. In: Mulliken JB, Young AE, editors. Vascular birthmarks: hemangiomas and malformations. Philadelphia: WB Saunders; 1988. p. 41–62.

    Google Scholar 

  39. Esterly NB. Cutaneous hemangiomas, vascular stains and malformations, and associated syndromes. Curr Probl Pediatr. 1996;26:3–39.

    CAS  PubMed  Google Scholar 

  40. Bowers RE, Graham EA, Tominson KM. The natural history of the strawberry nevus. Arch Dermatol. 1960;82:667–70.

    Article  Google Scholar 

  41. Chang LC, Haggstrom AN, Drolet BA, Baselga E, Chamlin SL, Garzon MC, et al. Growth characteristics of infantile hemangiomas: implications for management. Pediatrics. 2008;122:360–7.

    Article  PubMed  Google Scholar 

  42. Bitar MA, Moukarbel RV, Zalzal GH. Management of congenital subglottic hemangioma: trends and success over the past 17 years. Otolaryngol Head Neck Surg. 2005;132:226–31.

    Article  PubMed  Google Scholar 

  43. Perkins JA, Duke W, Chen E, Manning S. Emerging concepts in airway infantile hemangioma assessment and management. Otolaryngol Head Neck Surg. 2009;141:207–12.

    Article  PubMed  Google Scholar 

  44. Sie KC, McGill T, Healy GB. Subglottic hemangiomas: 10 years experience with the carbon dioxide laser. Ann Otol Rhinol Laryngol. 1994;103:167–72.

    Article  CAS  PubMed  Google Scholar 

  45. Orlow S, Isakoff M, Blei F. Increased risk of symptomatic hemangiomas of the airway in association with cutaneous hemangiomas in a “beard” distribution. J Pediatr. 1997;131:643–6.

    Article  CAS  PubMed  Google Scholar 

  46. O TM, Alexander RE, Lando T, et al. Segmental hemangiomas of the upper airway. Laryngoscope. 2009;119:2242–7.

    Article  PubMed  Google Scholar 

  47. Perkins JA, Chen EY, Hoffer FA, Manning SC. Proposal for staging airway hemangiomas. Otolaryngol Head Neck Surg. 2009;141:516–21.

    Article  PubMed  Google Scholar 

  48. North PE, Waner M, Mizeracki A, Mrak RE, Nicholas R, Kincannon J, et al. A unique microvascular phenotype shared by juvenile hemangiomas and human placenta. Arch Dermatol. 2001;137:559–70.

    Article  CAS  PubMed  Google Scholar 

  49. Badi AN, Kerschner JE, North PE, Drolet BA, Messner A, Perkins JA. Histopathologic and immunophenotypic profile of subglottic hemangioma: multicenter study. Int J Pediatr Otorhinolaryngol. 2009;73:1187–91.

    Article  PubMed  Google Scholar 

  50. Léauté-Labrèze C, Dumas de la Roque E, Hubiche T, Boralevi F, Thambo JB, Taïeb A. Propranolol for severe hemangiomas of infancy. N Engl J Med. 2008;358:2649–51.

    Article  PubMed  Google Scholar 

  51. Sans V, Dumas de la Roque E, Berge J, et al. Propranolol for severe infantile hemangiomas: follow-up report. Pediatrics. 2009;124:e423–31.

    Article  PubMed  Google Scholar 

  52. Tan ST, Itinteang T, Leadbitter P. Low-dose propranolol for multiple hepatic and cutaneous hemangiomas with deranged liver function. Pediatrics. 2011;127:e772–6.

    Article  PubMed  Google Scholar 

  53. Mousa W, Kues K, Haas E, et al. Successful treatment of a large hemangioma with propranolol. J Dtsch Dermatol Ges. 2010;8:184–6.

    Article  PubMed  Google Scholar 

  54. Marsciani A, Pericoli R, Alaggio R, Brisigotti M, Vergine G. Massive response of severe infantile hepatic hemangioma to propanolol. Pediatr Blood Cancer. 2010;54:176.

    Article  PubMed  Google Scholar 

  55. Saint-Jean M, Léauté-Labrèze C, Mazereeuw-Hautier J, Bodak N, Hamel-Teillac D, Kupfer-Bessaguet I, et al. Propranolol for treatment of ulcerated infantile hemangiomas. J Am Acad Dermatol. 2011;64:827–32.

    Article  CAS  PubMed  Google Scholar 

  56. Cheng JF, Gole GA, Sullivan TJ. Propranolol in the management of periorbital infantile haemangioma. Clin Experiment Ophthalmol. 2010;38:547–53.

    Article  PubMed  Google Scholar 

  57. Li YC, McCahon E, Rowe NA, Martin PA, Wilcsek GA, Martin FJ. Successful treatment of infantile haemangiomas of the orbit with propranolol. Clin Experiment Ophthalmol. 2010;38:554–9.

    Article  PubMed  Google Scholar 

  58. Fulkerson DH, Agim NG, Al-Shamy G, Metry DW, Izaddoost SA, Jea A. Emergent medical and surgical management of mediastinal infantile hemangioma with symptomatic spinal cord compression: case report and literature review. Childs Nerv Syst. 2010;26:1799–805.

    Article  PubMed  Google Scholar 

  59. Vanlander A, Decaluwe W, Vandelanotte M, Van Geet C, Cornette L. Propranolol as a novel treatment for congenital visceral haemangioma. Neonatology. 2010;98:229–31.

    Article  CAS  PubMed  Google Scholar 

  60. Theletsane T, Redfern A, Raynham O, Harris T, Prose NS, Khumalo NP. Life threatening infantile haemangioma: a dramatic response to propranolol. J Eur Acad Dermatol Venereol. 2009;23:1465–6.

    Article  CAS  PubMed  Google Scholar 

  61. Hogeling M, Adams S, Wargon O. A randomized controlled trial of propranolol for infantile hemangiomas. Pediatrics. 2011;128:e259–66.

    Article  PubMed  Google Scholar 

  62. Drolet BA, Frommelt PC, Chamlin SL, Haggstrom A, Bauman NM, Chiu YE, et al. Initiation and use of propranolol for infantile hemangioma: report of a consensus conference. Pediatrics. 2013;131:128–40.

    Article  PubMed  PubMed Central  Google Scholar 

  63. Greenberger S, Bischoff J. Infantile hemangioma-Mechanism(s) of drug action on a vascular tumor. Cold Spring Harb Perspect Med. 2011;1(1):a006460.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  64. Dai Y, Hou F, Buckmiller L, et al. Decreased eNOS protein expression in involuting and propranolol-treated hemangiomas. Arch Otolaryngol Head Neck Surg. 2012;138:177–82.

    Article  PubMed  Google Scholar 

  65. Frieden IJ, Drolet BA. Propranolol for infantile hemangiomas: promise, peril, pathogenesis. Pediatr Dermatol. 2009;26:642–4.

    Article  PubMed  Google Scholar 

  66. Mistry N, Tzifa K. Use of propranolol to treat multicentric airway haemangioma. J Laryngol Otol. 2010;7:1–4.

    Google Scholar 

  67. Truong MT, Chang KW, Berk DR, Heerema-McKenney A, Bruckner AL. Propranolol for the treatment of a life-threatening subglottic and mediastinal infantile hemangioma. J Pediatr. 2010;156:335–8.

    Article  PubMed  Google Scholar 

  68. Maturo S, Hartnick C. Initial experience using propranolol as the sole treatment for infantile airway hemangiomas. Int J Pediatr Otorhinolaryngol. 2010;74:323–5.

    Article  PubMed  Google Scholar 

  69. Buckmiller LM, Munson PD, Dyamenahalli U, Dai Y, Richter GT. Propranolol for infantile hemangiomas: early experience at a tertiary vascular anomalies center. Laryngoscope. 2010;120:676–81.

    Article  CAS  PubMed  Google Scholar 

  70. Manunza F, Syed S, Laguda B, et al. Propranolol for complicated infantile haemangiomas: a case series of 30 infants. Br J Dermatol. 2010;162:466–8.

    Article  CAS  PubMed  Google Scholar 

  71. Jephson CG, Manunza F, Syed S, Mills NA, Harper J, Hartley BE. Successful treatment of isolated subglottic haemangioma with propranolol alone. Int J Pediatr Otorhinolaryngol. 2009;73:1821–3.

    Article  PubMed  Google Scholar 

  72. Buckmiller L, Dyamenahalli U, Richter GT. Propranolol for airway hemangiomas: case report of novel treatment. Laryngoscope. 2009;119:2051–4.

    Article  PubMed  Google Scholar 

  73. Leboulanger N, Fayoux P, Teissier N, Cox A, Van Den Abbeele T, Carrabin L, et al. Propranolol in the therapeutic strategy of infantile laryngotracheal hemangioma: A preliminary retrospective study of French experience. Int J Pediatr Otorhinolaryngol. 2010;74:1254–7.

    Article  PubMed  Google Scholar 

  74. Anderson de Moreno LC, Matt BH, Montgomery G, Kim YJ. Propranolol in the treatment of upper airway hemangiomas. Ear Nose Throat J. 2013;92:209–14.

    PubMed  Google Scholar 

  75. Mahadevan M, Cheng A, Barber C. Treatment of subglottic hemangiomas with propranolol: initial experience in 10 infants. ANZ J Surg. 2011;81:456–61.

    Article  PubMed  Google Scholar 

  76. Rosbe KW, Suh KY, Meyer AK, Maguiness SM, Frieden IJ. Propranolol in the management of airway infantile hemangiomas. Arch Otolaryngol Head Neck Surg. 2010;136:658–65.

    Article  PubMed  Google Scholar 

  77. Raol N, Metry D, Edmonds J, Chandy B, Sulek M, Larrier D. Propranolol for the treatment of subglottic hemangiomas. Int J Pediatr Otorhinolaryngol. 2011;75:1510–4.

    Article  PubMed  Google Scholar 

  78. Bajaj Y, Kapoor K, Ifeacho S, Jephson CG, Albert DM, Harper JI, et al. Great Ormond Street Hospital treatment guidelines for use of propranolol in infantile isolated subglottic haemangioma. J Laryngol Otol. 2013;127:295–8.

    Article  CAS  PubMed  Google Scholar 

  79. Parikh SR, Darrow DH, Grimmer JF, Manning SC, Richter GT, Perkins JA. Propranolol use for infantile hemangiomas: American Society of Pediatric Otolaryngology Vascular Anomalies Task Force practice patterns. JAMA Otolaryngol Head Neck Surg. 2013;139:153–6.

    Article  PubMed  Google Scholar 

  80. Lawley LP, Siegfried E, Todd JL. Propranolol treatment for hemangioma of infancy: risks and recommendations. Pediatr Dermatol. 2009;26:610–4.

    Article  PubMed  Google Scholar 

  81. Denoyelle F, Garabédian EN. Propranolol may become first-line treatment in obstructive subglottic infantile hemangiomas. Otolaryngol Head Neck Surg. 2010;142:463–4.

    Article  PubMed  Google Scholar 

  82. Waner M, Suen JY. Treatment options for the management of hemangiomas. In: Waner M, Suen JY, editors. Hemangiomas and vascular malformations of the head and neck. New York: Wiley-Liss, Inc.; 1999. p. 233–62.

    Google Scholar 

  83. Waner M, Suen JY. Advances in the management of congenital vascular lesions of the head and neck. Adv Otorhinolaryngol. 1996;10:31–54.

    Google Scholar 

  84. Ezekowitz RAB, Mulliken JB, Folkman J. Interferon alfa-2A therapy for life-threatening hemangiomas of infancy. N Engl J Med. 1992;326:1456–63.

    Article  CAS  PubMed  Google Scholar 

  85. Ohlms LA, Jones DT, McGill TJ, Healy GB. Interferon alfa2A therapy for airway hemangiomas. Ann Otol Rhinol Laryngol. 1994;103:1–8.

    Article  CAS  PubMed  Google Scholar 

  86. Bauman MN, Burke DK, Smith RJH. Treatment of massive or life-threatening hemangiomas with recombinant α 2a-interferon. Otolaryngol Head Neck Surg. 1997;117:99–110.

    Article  CAS  PubMed  Google Scholar 

  87. MacArthur CJ, Senders CW, Katz J. The use of interferon Alfa-2A for life-threatening hemangiomas. Arch Otolaryngol Head Neck Surg. 1995;121:690–3.

    Article  CAS  PubMed  Google Scholar 

  88. Barlow CF, Priebe CJ, Mulliken JB, et al. Spastic diplegia as a complication of interferon Alpha-2a treatment of hemangiomas of infancy. J Pediatr. 1998;132:527–30.

    Article  CAS  PubMed  Google Scholar 

  89. Michaud AP, Bauman NM, Burke DK, Manaligod JM, Smith RJ. Spastic diplegia and other motor disturbances in infants receiving interferon-alpha. Laryngoscope. 2004;114:1231–6.

    Article  CAS  PubMed  Google Scholar 

  90. Hoeve LJ, Kuppers GLE, Verwoerd CDA. Management of infantile subglottic hemangioma: laser vaporization, submucous resection, intubation or intralesional steroids? Int J Pediatr Otorhinolaryngol. 1997;42:179–86.

    Article  CAS  PubMed  Google Scholar 

  91. Walker P, Cooper D, MacDonald D. Subglottic haemangioma: controversies in management. J Paediatr Child Health. 1999;35:392–5.

    Article  CAS  PubMed  Google Scholar 

  92. Re M, Forte V, Berardi C, Mallardi V. Role of endoscopic CO2 laser surgery in the treatment of congenital infantile subglottic hemangioma. Experience in the Department of Otolaryngology, “Sick Children Hospital”, Toronto, Canada. Acta Otorhinolaryngol Ital. 2003;23:175–9.

    CAS  PubMed  Google Scholar 

  93. Madgy D, Ahsan SF, Kest D, Stein I. The application of the Potassium-Titanyl-Phosphate (KTP) laser in the management of subglottic hemangioma. Arch Otolaryngol Head Neck Surg. 2001;127:47–50.

    Article  CAS  PubMed  Google Scholar 

  94. Kacker A, April M, Ward RF. Use of potassium titanyl phosphate (KTP) laser in management of subglottic hemangiomas. Int J Pediatr Otorhinolaryngol. 2001;59:15–21.

    Article  CAS  PubMed  Google Scholar 

  95. Fu CH, Lee LA, Fang TJ, Wong KS, Li HY. Endoscopic Nd:YAG laser therapy of infantile subglottic hemangioma. Pediatr Pulmonol. 2007;42:89–92.

    Article  PubMed  Google Scholar 

  96. Azizkhan RG. Laser surgery: new applications for pediatric skin and airway lesions. Curr Opin Pediatr. 2003;15:243–7.

    Article  PubMed  Google Scholar 

  97. Cotton RT, Tewfik T. Laryngeal stenosis following carbon dioxide laser in subglottic hemangioma. Ann Otol Rhinol Laryngol. 1985;94:494–7.

    CAS  PubMed  Google Scholar 

  98. Pransky SM, Canto C. Management of subglottic hemangioma. Curr Opin Otolaryngol Head Neck Surg. 2004;12:509–12.

    Article  PubMed  Google Scholar 

  99. Jai H, Huang Q, Lü J, Li J, Zhang Z, Wang Z, et al. Microdebrider removal under suspension laryngoscopy: an alternative surgical technique for subglottic hemangioma. Int J Pediatr Otorhinolaryngol. 2013;77:1424–9.

    Article  Google Scholar 

  100. Froehlich P, Stamm D, Floret D, Morgon A. Management of subglottic hemangioma. Clin Otolaryngol. 1995;4:336–9.

    Article  Google Scholar 

  101. Wiatrak BJ, Reilly JS, Seid AD, Pransky SM, Castillo JV. Open surgical excision of subglottic hemangioma in children. Int J Pediatr Otorhinolaryngol. 1996;34:191–206.

    Article  CAS  PubMed  Google Scholar 

  102. Van Den Abbeele T, Triglia J-M, Lescanne E, et al. Surgical removal of subglottic hemangiomas in children. Laryngoscope. 1999;109:1281–6.

    Article  Google Scholar 

  103. Vijayasekaran S, White D, Hartley BEJ, Rutter MJ, Elluru RG, Cotton RT. Open excision of subglottic hemangiomas to avoid tracheostomy. Arch Otolaryngol Head Neck Surg. 2006;132:159–63.

    Article  PubMed  Google Scholar 

  104. Bajaj Y, Hartley BEJ, Wyatt ME, Albert DM, Bailey CM. Subglottic haemangioma in children: experience with open surgical excision. J Laryngol Otol. 2006;120:1033–7.

    CAS  PubMed  Google Scholar 

  105. O-Lee TJ, Messner A. Open excision of subglottic hemangioma with microscopic dissection. Int J Pediatr Otorhinolaryngol. 2007;71:1371–6.

    Article  CAS  PubMed  Google Scholar 

  106. Frieden IJ, Reese V, Cohen D. PHACE syndrome: the association of posterior fossa brain malformations, hemangiomas, arterial anomalies, coarctation of the aorta and cardiac defects, and eye abnormalities. Arch Dermatol. 1996;132:307–11.

    Article  CAS  PubMed  Google Scholar 

  107. Durr ML, Meyer AK, Huoh KC, Frieden IJ, Rosbe KW. Airway hemangiomas in PHACE syndrome. Laryngoscope. 2012;122:2323–9.

    Article  PubMed  Google Scholar 

  108. Haggstrom AN, Skillman S, Garzon MC, Drolet BA, Holland K, Matt B, et al. Clinical spectrum and risk of PHACE syndrome in cutaneous and airway hemangiomas. Arch Otolaryngol Head Neck Surg. 2011;137:680–7.

    Article  PubMed  Google Scholar 

  109. Duyka LJ, Fan CY, Coviello-Malle JM, Buckmiller L, Suen JY. Progesterone receptors identified in vascular malformations of the head and neck. Otolaryngol Head Neck Surg. 2009;141:491–5.

    Article  PubMed  Google Scholar 

  110. Rahbar R, Rowley H, Perez-Atayde AR, McGill TJ, Healy GB. Delayed presentation of lymphatic malformation of the cervicofacial region: role of trauma. Ann Otol Rhinol Laryngol. 2002;111:828–31.

    Article  PubMed  Google Scholar 

  111. Ohlms LA, Forsen J, Burrows PE. Venous malformation of the pediatric airway. Int J Pediatr Otorhinolaryngol. 1996;37:99–114.

    Article  CAS  PubMed  Google Scholar 

  112. Thompson DM, Kasperbauer JL. Congenital cystic hygroma involving the larynx presenting as an airway emergency. J Natl Med Assoc. 1994;86:629–32.

    CAS  PubMed  PubMed Central  Google Scholar 

  113. O TM, Rickert SM, Diallo AM, et al. Lymphatic malformations of the airway. Otolaryngol Head Neck Surg. 2013;149:156–60.

    Article  PubMed  Google Scholar 

  114. Richter GT, Braswell L. Management of venous malformations. Facial Plast Surg. 2012;28:603–10.

    Article  CAS  PubMed  Google Scholar 

  115. Konez O, Burrows PE, Mulliken JB. Cervicofacial venous malformations. MRI features and interventional strategies. Interv Neuroradiol. 2002;8:227–34.

    CAS  PubMed  PubMed Central  Google Scholar 

  116. Manning SC, Perkins J. Lymphatic malformations. Curr Opin Otolaryngol Head Neck Surg. 2013;21:571–5.

    Article  PubMed  Google Scholar 

  117. Kennedy TL, Whitaker M, Pellitteri P, Wood WE. Cystic hygroma/lymphangioma: a rational approach to management. Laryngoscope. 2001;111:1929–37.

    Article  CAS  PubMed  Google Scholar 

  118. Padwa BL, Hayward PG, Ferraro NF, Mulliken JB. Cervicofacial lymphatic malformation: clinical course, surgical intervention, and pathogenesis of skeletal hypertrophy. Plast Reconstr Surg. 1995;95:951–60.

    Article  CAS  PubMed  Google Scholar 

  119. Harsha WJ, Perkins JA, Lewis CW, Manning SC. Pediatric admissions and procedures for lymphatic malformations in the United States: 1997 and 2000. Lymphat Res Biol. 2005;3:58–65.

    Article  PubMed  Google Scholar 

  120. Hassanein AH, Mulliken JB, Fishman SJ, Quatrano NA, Zurakowski D, Greene AK. Lymphatic malformation: risk of progression during childhood and adolescence. J Craniofac Surg. 2012;23:149–52.

    Article  PubMed  Google Scholar 

  121. Smith RJ, Burke DK, Sato Y, Poust RI, Kimura K, Bauman NM. OK-432 therapy for lymphangiomas. Arch Otolaryngol Head Neck Surg. 1996;122:1195–9.

    Article  CAS  PubMed  Google Scholar 

  122. Edwards PD, Rahbar R, Ferraro NF, Burrows PE, Mulliken JB. Lymphatic malformation of the lingual base and oral floor. Plast Reconstr Surg. 2005;115:1906–15.

    Article  CAS  PubMed  Google Scholar 

  123. Wiegand S, Eivazi B, Zimmermann AP, et al. Microcystic lymphatic malformations of the tongue: diagnosis, classification, and treatment. Arch Otolaryngol Head Neck Surg. 2009;135:976–83.

    Article  PubMed  Google Scholar 

  124. Stefini S, Bazzana T, Smussi C, et al. EXIT (Ex utero Intrapartum Treatment) in lymphatic malformations of the head and neck: discussion of three cases and proposal of an EXIT-TTP (Team Time Procedure) list. Int J Pediatr Otorhinolaryngol. 2012;76:20–7.

    Article  PubMed  Google Scholar 

  125. Lei ZM, Huang XX, Sun ZJ, Zhang WF, Zhao YF. Surgery of lymphatic malformations in oral and cervicofacial regions in children. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2007;104:338–44.

    Article  PubMed  Google Scholar 

  126. Perkins JA, Manning SC, Tempero RM, Cunningham MJ, Edmonds Jr JL, Hoffer FA, et al. Lymphatic malformations: review of current treatment. Otolaryngol Head Neck Surg. 2010;142:795–803. 803 e791.

    Article  PubMed  Google Scholar 

  127. Renton JP, Smith RJ. Current treatment paradigms in the management of lymphatic malformations. Laryngoscope. 2011;121:56–9.

    Article  PubMed  Google Scholar 

  128. Dubois J, Alison M. Vascular anomalies: what a radiologist needs to know. Pediatr Radiol. 2010;40:895–905.

    Article  PubMed  Google Scholar 

  129. Dasgupta R, Adams D, Elluru R, Wentzel MS, Azizkhan RG. Noninterventional treatment of selected head and neck lymphatic malformations. J Pediatr Surg. 2008;43:869–73.

    Article  PubMed  Google Scholar 

  130. Perkins JA, Maniglia C, Magit A, Sidhu M, Manning SC, Chen EY. Clinical and radiographic findings in children with spontaneous lymphatic malformation regression. Otolaryngol Head Neck Surg. 2008;138:772–7.

    Article  PubMed  Google Scholar 

  131. Boardman SJ, Cochrane LA, Roebuck D, Elliott MJ, Hartley BE. Multimodality treatment of pediatric lymphatic malformations of the head and neck using surgery and sclerotherapy. Arch Otolaryngol Head Neck Surg. 2010;136:270–6.

    Article  PubMed  Google Scholar 

  132. Nehra D, Jacobson L, Barnes P, Mallory B, Albanese CT, Sylvester KG. Doxycycline sclerotherapy as primary treatment of head and neck lymphatic malformations in children. J Pediatr Surg. 2008;43:451–60.

    Article  PubMed  Google Scholar 

  133. Smith MC, Zimmerman MB, Burke DK, Bauman NM, Sato Y, Smith RJ. Efficacy and safety of OK-432 immunotherapy of lymphatic malformations. Laryngoscope. 2009;119:107–15.

    Article  CAS  PubMed  Google Scholar 

  134. Cahill AM, Nijs E, Ballah D, et al. Percutaneous sclerotherapy in neonatal and infant head and neck lymphatic malformations: a single center experience. J Pediatr Surg. 2011;46:2083–95.

    Article  PubMed  Google Scholar 

  135. Shiels 2nd WE, Kang DR, Murakami JW, Hogan MJ, Wiet GJ. Percutaneous treatment of lymphatic malformations. Otolaryngol Head Neck Surg. 2009;141:219–24.

    Article  PubMed  Google Scholar 

  136. Chen WL, Zhang B, Wang JG, Ye HS, Zhang DM, Huang ZQ. Surgical excision of cervicofacial giant macrocystic lymphatic malformations in infants and children. Int J Pediatr Otorhinolaryngol. 2009;73:833–7.

    Article  PubMed  Google Scholar 

  137. Otteson TD, Hackam DJ, Mandell DL. The Ex Utero Intrapartum Treatment (EXIT) procedure: new challenges. Arch Otolaryngol Head Neck Surg. 2006;132:686–9.

    Article  PubMed  Google Scholar 

  138. Burrows PE, Mitri RK, Alomari A, et al. Percutaneous sclerotherapy of lymphatic malformations with doxycycline. Lymphat Res Biol. 2008;6:209–16.

    Article  CAS  PubMed  Google Scholar 

  139. Bai Y, Jia J, Huang XX, Alsharif MJ, Zhao JH, Zhao YF. Sclerotherapy of microcystic lymphatic malformations in oral and facial regions. J Oral Maxillofac Surg. 2009;67:251–6.

    Article  PubMed  Google Scholar 

  140. Sobol SE, Manoukian JJ. Acute airway obstruction from a laryngeal lymphangioma in a child. Int J Pediatr Otorhinolaryngol. 2001;58:255–7.

    Article  CAS  PubMed  Google Scholar 

  141. Kenton A, Duncan N, Bhakta K, Fernandes CJ. Laryngeal lymphatic malformation in a newborn. J Perinatol. 2003;23:567–71.

    Article  PubMed  Google Scholar 

  142. Chan J, Younes A, Koltai PJ. Occult supraglottic lymphatic malformation presenting as obstructive sleep apnea. Int J Pediatr Otorhinolaryngol. 2003;67:293–6.

    Article  PubMed  Google Scholar 

  143. Berg EE, Sobol SE, Jacobs I. Laryngeal obstruction by cervical and endolaryngeal lymphatic malformations in children: proposed staging system and review of treatment. Ann Otol Rhinol Laryngol. 2013;122:575–81.

    Article  PubMed  Google Scholar 

  144. Brouillard P, Vikkula M. Genetic causes of vascular malformations. Hum Mol Genet. 2007;16(Spec No. 2):R140–9.

    Article  CAS  PubMed  Google Scholar 

  145. Hassanein AH, Mulliken JB, Fishman SJ, Alomari AI, Zurakowski D, Greene AK. Venous malformation: risk of progression during childhood and adolescence. Ann Plast Surg. 2012;68:198–201.

    Article  CAS  PubMed  Google Scholar 

  146. Gallione CJ, Pasyk KA, Boon LM, et al. A gene for familial venous malformations maps to chromosome 9p in a second large kindred. J Med Genet. 1995;32:197. e9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  147. Eifert S, Villavicencio JL, Kao TC, Taute BM, Rich NM. Prevalence of deep venous anomalies in congenital vascular malformations of venous predominance. J Vasc Surg. 2000;31(3):462–71.

    Article  CAS  PubMed  Google Scholar 

  148. Gloviczki P, Stanson AW, Stickler GB, Johnson CM, Toomey BJ, Meland NB, Rooke TW, Cherry Jr KJ. Klippel-Trenaunay syndrome: the risks and benefits of vascular interventions. Surgery. 1991;110(3):469–79.

    CAS  PubMed  Google Scholar 

  149. Glade RS, Richter GT, James CA, Suen JY, Buckmiller LM. Diagnosis and management of pediatric cervicofacial venous malformations: retrospective review from a vascular anomalies center. Laryngoscope. 2010;120:229–35.

    Article  PubMed  Google Scholar 

  150. Dompmartin A, Vikkula M, Boon LM. Venous malformation: update on aetiopathogenesis, diagnosis and management. Phlebology. 2010;25:224–35.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  151. Eivazi B, Wiegand S, Teymoortash A, Neff A, Werner JA. Laser treatment of mucosal venous malformations of the upper aerodigestive tract in 50 patients. Lasers Med Sci. 2010;25:571–6.

    Article  PubMed  Google Scholar 

  152. Scherer K, Waner M. Nd:YAG lasers (1,064 nm) in the treatment of venous malformations of the face and neck: challenges and benefits. Lasers Med Sci. 2007;22:119–26.

    Article  PubMed  Google Scholar 

  153. Glade R, Vinson K, Richter G, Suen JY, Buckmiller LM. Endoscopic management of airway venous malformations with Nd:YAG laser. Ann Otol Rhinol Laryngol. 2010;119:289–93.

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to David H. Darrow M.D., D.D.S. .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2015 Springer Science+Business Media New York

About this chapter

Cite this chapter

Darrow, D.H., Richter, G.T. (2015). Vascular Anomalies of the Neonatal Airway. In: Lioy, J., Sobol, S. (eds) Disorders of the Neonatal Airway. Springer, New York, NY. https://doi.org/10.1007/978-1-4939-1610-8_12

Download citation

  • DOI: https://doi.org/10.1007/978-1-4939-1610-8_12

  • Published:

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-1-4939-1609-2

  • Online ISBN: 978-1-4939-1610-8

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics